A meta-analysis investigating the relationship between lncRNA MALAT1 expression and prognosis in bladder cancer found that elevated levels of lncRNA MALAT1 are associated with a poor prognosis and an increased risk of lymph node metastasis in these patients (81). Here, MALAT1 is linked to urinary bladder carcinoma.